{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000504831-2017-11-10T00:00:00Z",
    "date": "2017-11-10T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000504831",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-33",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "lauraferguson1@nhs.net",
                "telephone": "+44 1312756725",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-17",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Patrick Mulraney",
                "email": "pmulraney@nhs.net",
                "telephone": "+44 1698794410",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-17"
    },
    "tender": {
        "id": "NP47217",
        "title": "Efavirenz 600mg/Emtricitabine 200mg/Tenofovir Disoproxil 245mg Tablets",
        "description": "Supply of efavirenz 600mg/emtricitabine 200mg/tenofovir disoproxil 245mg tablets to NHS Scotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 11750000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk",
        "tenderPeriod": {
            "endDate": "2017-08-25T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2017-08-25T12:00:00Z"
        },
        "documents": [
            {
                "id": "JUL290276",
                "documentType": "contractNotice",
                "title": "Efavirenz 600mg/Emtricitabine 200mg/Tenofovir Disoproxil 245mg Tablets",
                "description": "Supply of efavirenz 600mg/emtricitabine 200mg/tenofovir disoproxil 245mg tablets to NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL290276",
                "format": "text/html"
            },
            {
                "id": "NOV300894",
                "documentType": "awardNotice",
                "title": "Efavirenz 600mg/Emtricitabine 200mg/Tenofovir Disoproxil 245mg Tablets",
                "description": "Supply of efavirenz 600mg/emtricitabine 200mg/tenofovir disoproxil 245mg tablets to NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV300894",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "This procurement is for the supply of efavirenz 600mg/emtricitabine 200mg/tenofovir disoproxil 245mg tablets to NHS Scotland. This will require supply of the medicines direct to hospitals and the nominated home delivery supplier(s) as directed by the Authority. The product line will be awarded to a single supplier. Full detail of the product description and quantity is detailed in the ITT.",
                "status": "complete",
                "value": {
                    "amount": 11750000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 480
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                }
            }
        ],
        "bidOpening": {
            "date": "2017-08-25T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situations referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines prior to the commencement of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All Goods must comply with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
                    "minimum": "(a) Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines will be in place prior to the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under Technical and Professional Ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional Ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional Ability: Products."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 1
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false
    },
    "language": "EN",
    "description": "The estimated values referred to in Sections II.I.7 and V.2.4 cover the initial sixteen (16) month duration and the two (2) extension periods of up to twelve (12) months each. (SC Ref:517489)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000504831"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000504831"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP47217",
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP47217",
            "awardID": "NP47217",
            "status": "active",
            "dateSigned": "2017-10-18T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2017/S 140-287293"
        }
    ]
}